In March 2016 NICE commenced the review of this guidance, to register as a stakeholder please contact us at

NICE has developed medical technology guidance on the moorLDI2-BI.

NICE medical technology guidance addresses specific technologies notified to NICE by manufacturers. The ‘case for adoption’ recommendations are based on the claimed advantages of introducing the specific technology compared with current management of the condition. This ‘case’ is reviewed against the evidence submitted and expert advice. If the case for adopting the technology is supported, then the technology has been found to offer advantages to patients and the NHS. The specific recommendations on individual technologies are not intended to limit use of other relevant technologies which may offer similar advantages.

NICE has said that the moorLDI2-BI can be used to help make decisions about treatment in patients when experienced healthcare professionals aren’t sure about how deep the burn wound is or how long it might take to heal. Hospital teams may want to use the moorLDI2-BI because the evidence showed that decisions about whether to use surgery could be made earlier, meaning less time spent in hospital. It could also reduce the size of areas that are operated on, or avoid the need for surgery completely in some patients who otherwise might have had to have surgery.

  • National Institute for Health and Care Excellence (NICE) accreditation logo